Population Landscape of Familial Cancer
Authors
Affiliations
Public perception and anxiety of familial cancer have increased demands for clinical counseling, which may be well equipped for gene testing but less prepared for counseling of the large domain of familial cancer with unknown genetic background. The aim of the present study was to highlight the full scope of familial cancer and the variable levels of risk that need to be considered. Data on the 25 most common cancers were obtained from the Swedish Family Cancer Database and a Poisson regression model was applied to estimate relative risks (RR) distinguishing between family histories of single or multiple affected first-degree relatives and their diagnostic ages. For all cancers, individual risks were significantly increased if a parent or a sibling had a concordant cancer. While the RRs were around 2.00 for most cancers, risks were up to 10-fold increased for some cancers. Familial risks were even higher when multiple relatives were affected. Although familial risks were highest at ages below 60 years, most familial cases were diagnosed at older ages. The results emphasized the value of a detailed family history as a readily available tool for individualized counseling and its preventive potential for a large domain of non-syndromatic familial cancers.
Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes.
Hemminki K, Kiemeney L, Morgans A, Ranniko A, Pichler R, Hemminki O Eur Urol Open Sci. 2024; 69:13-20.
PMID: 39314911 PMC: 11416669. DOI: 10.1016/j.euros.2024.08.011.
Describing patterns of familial cancer risk in subfertile men using population pedigree data.
Ramsay J, Madsen M, Horns J, Hanson H, Camp N, Emery B Hum Reprod. 2024; 39(4):822-833.
PMID: 38383051 PMC: 10988109. DOI: 10.1093/humrep/dead270.
Two Distinct Deleterious Causative Variants in a Family with Multiple Cancer-Affected Patients.
Khorram E, Tabatabaiefar M, Zeinalian M Adv Biomed Res. 2023; 12:203.
PMID: 37694253 PMC: 10492615. DOI: 10.4103/abr.abr_366_22.
Proactive familial cancer risk assessment: a service development study in UK primary care.
Badran A, Youngs A, Forman A, Elms M, Chang L, Lebbe F BJGP Open. 2023; 7(4).
PMID: 37591554 PMC: 11176673. DOI: 10.3399/BJGPO.2023.0076.
Melanoma risk prediction based on a polygenic risk score and clinical risk factors.
Wong C, Dite G, Spaeth E, Murphy N, Allman R Melanoma Res. 2023; 33(4):293-299.
PMID: 37096571 PMC: 10309112. DOI: 10.1097/CMR.0000000000000896.